Your session is about to expire
← Back to Search
Voiding Protocols After Minimally Invasive Hysterectomy
Study Summary
This trialwill see if strict vs. liberal voiding affects post-op outcomes for patients discharged same-day after minimally invasive hysterectomy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a woman over 18 having a minor surgery to remove my uterus for non-cancer reasons.My bladder was injured during surgery.I stayed in the hospital overnight after not being discharged the same day.I have a diagnosed urinary disease.I have had surgery for prolapse or incontinence.My surgeon may decide to remove me from the study after surgery.My surgery involves multiple surgical teams.I have had surgery or procedures on my urinary system before.
- Group 1: Strict need to void following surgery before discharge
- Group 2: No strict need to void following surgery before discharge
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the participant count of this clinical investigation?
"Indeed, the details outlined on clinicaltrials.gov affirm that this medical trial is seeking participants. This research was originally announced December 5th 2022 and has since been updated on December 12th 2022. The study requires 100 individuals spread across 1 centre to take part in it."
Are there still opportunities for participation in this medical experiment?
"Affirmative. According to information on clinicaltrials.gov, the trial that was initially launched on December 5th 2022 is now recruiting participants. 100 patients must be enrolled across a single site in order for this study to move forward successfully."
Share this study with friends
Copy Link
Messenger